We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STT:NYSEState Street Corporation Analysis

Data as of 2026-09-11 - not real-time

$193.81

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

State Street Corporation trades at $193.81, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 6.0%. With RSI at 58.6 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $182.96 and resistance at $195.93.
Multiples put this in fair territory: 17.1 times earnings against the sector's 16.2. Revenue is contracting at 2.8% on a 23.0% profit margin. The 1.92% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 19.5%, a beta of 1.06 and a maximum drawdown of 11.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top Market Events

State Street stock trades above $190 after a strong second-quarter earnings beat and dividend increaLooking back on custody bank stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including...Does State Street Corporation STT have what it takes to be a top stock pick for momentum investors?

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 150.55
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 17.1 versus sector average of 16.2
  • Trading above the 200-day average of 150.55

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 17.1 versus sector average of 16.2
  • Profit margin of 23.0% is healthy
  • Revenue contracting at -2.8%

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin23.00%
P/E Ratio17.1
ROE12.44%
ROA0.87%
P/B Ratio2.2
Op. Cash Flow$3.5B
Industry P/E16.2

Technical Analysis

TrendBullish
RSI58.6
Support$182.96
Resistance$195.93
MA 20$191.16
MA 50$186.29
MA 200$150.55
MACDBearish
VolumeStable
Fear & Greed Index93.29

Valuation

Fair Value$111.16
Target Price$199.50
Upside/Downside2.94%
GradeFair
TypeBlend
Dividend Yield1.92%

Risk Assessment

Beta1.06
Volatility19.55%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.